- Home
- TONX vs DTIL Comparison
TONX vs DTIL Comparison
Compare TONX & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | DTIL |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.5M | 128.8M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | TONX | DTIL |
|---|---|---|
| Price | $2.66 | $6.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | ★ 361.6K | 307.4K |
| Earning Date | 05-12-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,070,000,000.00 |
| Revenue This Year | $526.82 | N/A |
| Revenue Next Year | $45.45 | $34.75 |
| P/E Ratio | $0.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $3.53 |
| 52 Week High | $8.23 | $8.82 |
Technical Indicators
Market Signals| Indicator | TONX | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 50.20 | 67.35 |
| Support Level | $1.80 | $3.96 |
| Resistance Level | $3.61 | $8.82 |
| Average True Range (ATR) | 0.29 | 0.54 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 23.66 | 61.06 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.